Eps15-homology domain containing protein 2 (EHD2) is a dynamin-related ATPase located at the neck of 27 caveolae, but its physiological function has remained unclear. Here, we found that global genetic ablation 28 of EHD2 in mice led to increased fat accumulation. This organismic phenotype was paralleled at the 29 cellular level by increased lipid uptake via a caveolae-, dynamin-and CD36-dependent pathway, an 30 elevated number of detached caveolae and higher caveolar mobility. Furthermore, EHD2 expression itself 31 was down-regulated in the visceral fat of two obese mouse models and obese patients. Our data suggest 32 that EHD2 controls a cell-autonomous, caveolae-dependent lipid uptake pathway and suggest that low 33 EHD2 expression levels are linked to obesity. 
Introduction 39
Caveolae are small membrane invaginations of the plasma membrane that are abundantly found 40 in adipocytes, endothelial and muscle cells (1). They have been implicated in the regulation of membrane 41 tension (2, 3), in mediating lipid metabolism (4), or in acting as distinct sites for specific and highly 42 regulated signaling cascades such as the endothelial nitric oxide synthase (eNOS)-nitric oxide (NO) 43 pathway (5). The characteristically shaped caveolar bulb has a typical diameter of 50 -100 nm and is 44 connected to the cell surface via a narrow neck region. The integral membrane protein Caveolin (with 45 three isoforms in human, Cav1-3) and the peripheral membrane protein Cavin (with four isoforms in 46 human, Cavin1-4) build a mesh-like coat around the caveolar bulb (6-10). In addition, BAR domain 47 containing proteins of the PACSIN/syndapin family (PACSIN1-3 in human) participate in the biogenesis of 48 caveolae (11-13). 49
Loss of Cav1/Cav3 or Cavin1 results in a complete lack of caveolae from the plasma membrane (4, 50 14, 15). Cav1 KO mice suffer from cardiomyopathy, pulmonary hypertension, endothelium-dependent 51 relaxation problems and defective lipid metabolism (1). In agreement with the latter, Cav1 KO mice are 52 resistant to high fat diet-induced obesity (16) and display smaller white adipocytes and fat pads (17) . 53
Furthermore, increased levels of triglycerides and fatty acids are found in blood plasma samples obtained 54 from Cav1 KO mice suggesting a reduced cellular uptake of fatty acids (16). A similar metabolic phenotype 55 was found in mice lacking Cavin1 (4, 18). Conversely, overexpression of Cav1 in adipocytes results in an 56 increased number of caveolae, enhanced fat accumulation, enlarged adipocytes and lipid droplets (LDs) 57 (19). These results suggest that caveolae are involved in lipid accumulation in adipocytes and may 58 promote fatty acid uptake (20) . However, the molecular mechanisms of caveolae-dependent fat uptake 59 have remained obscure. 60
Eps15 homology domain containing protein 2 (EHD2) localizes to the caveolar neck region (6, 21, 61 22). The protein belongs to the dynamin-related EHD ATPase family, which comprises four members in 62
Results

87
Generation of EHD2 knockout mice 88
To examine the physiological function of EHD2, a mouse strain with LoxP recognition sites 89 surrounding exon 3 and intron 3 of the Ehd2 gene was engineered (Fig. 1A) . Exon 3 encodes part of the 90 highly conserved GTPase domain (residues 137-167), and its deletion is predicted to result in non-91 functional protein. Following global removal of exon 3 by crossings with a germ-line specific Cre-deleter 92 strain, offspring mice were back-crossed with the C57BL6/N mouse strain for five generations, yielding a 93 global EHD2 KO mouse model. Genotyping of offspring confirmed the successful deletion of EHD2 exon 3 94 in EHD2 del/del animals ( Fig. S1A ) and real-time PCR revealed the absence of EHD2 mRNA in the EHD2 95 del/del tissue (Fig. 1B) . Western blot analysis indicated the complete loss of EHD2 in WAT and various 96 other tissues of EHD2 del/del mice compared to abundant EHD2 expression in EHD2 +/+ mice (Fig. 1C, Fig.  97 S1B-D). Cav1 and Cavin1 protein levels remained grossly unaltered upon loss of EHD2 (Fig. 1C, Fig. S1D ). 98 Accordingly, immunostaining of cryostat sections obtained from EHD2 del/del BAT did not reveal apparent 99 differences in Cav1 or Cavin1 expression and localization (Fig. S1E ), whereas EHD2 staining was completely 100 abolished ( Fig. 1D) . 101
102
Loss of EHD2 results in increased lipid accumulation 103
EHD2 del/del mice were born in normal Mendelian ratios, were fertile and did not show any 104 obvious phenotype upon initial inspection. In contrast to the reported loss of white fat mass in Cav1 and 105
Cavin1 KO mouse models (4, 16, 17), one year-old EHD2 del/del male mice were not apparently 106 lipodystrophic and did not display any detectable weight difference when compared to EHD2 del/+ mice 107 (Fig. 1E) . However, analysis of the lipid composition in WAT indicated an increased amount of storage 108 lipids (mainly triacylglycerol) in EHD2 del/del mice compared to EHD2 del/+ (Fig. 1F ). This suggested that 109 these mice suffered from a more subtle phenotype. Indeed, several of the EHD2 del/del mice showed 110 increased deposits of epigonadal and periinguinal white fat (Fig. 1G) indicating that the storage capacity 111 of normal adipose tissue was dysregulated. 112 When analyzed at the cellular level, white adipocytes of EHD2 del/del mice showed an increased 113 cell size compared to adipocytes from EHD2 del/+ mice or adult C57BL6/N mice (Fig. 1H, Fig. S2A ), likely 114 due to increased lipid storage. In contrast to EHD2 del/+ BAT with its distinct brown appearance, EHD2 115 del/del BAT showed increased beige and white coloring (Fig. 1I ). Histological inspections of BAT paraffin 116 and cryostat sections stained against the LD coat protein Perilipin1 indicated an increased LD size in EHD2 117 del/del BAT compared to EHD2 del/+ or C57BL6/N mice (Fig. 1J, Fig. S2B-C) . As no significant differences 118 lipid accumulation (Fig. S2) were found in EHD2 del/+ and C57BL6/N male mice and to reduce animal 119 numbers, the following experiments were carried out with EHD2 del/+ as control group to EHD2 del/del 120 male mice. 121
Based on the increased lipid accumulation in EHD2-lacking adipocyte tissue, we further 122 investigated if adipocyte differentiation is altered in EHD2 del/del WAT. However, adipogenic marker 123 genes like PPARγ, Retn or Serpina3k displayed no significant expression change in EHD2 del/del WAT 124 compared to EHD2 del/+ WAT (Fig. S2D) . The weight adaptation of both genotypes suggested the 125 occurrence of compensatory mechanisms. First, we looked for changes of adiponectin, leptin and insulin 126 plasma levels but did not detect any significant difference in mice lacking EHD2 compared to EHD2 del/+ 127 mice (Fig. S3) . Free fatty acid concentration in blood plasma was slightly reduced in EHD2 del/del 128 suggesting a possible increase in fatty acid uptake (Fig. S3) . Furthermore, we observed a down-regulation 129 of genes involved in de novo lipogenesis in isolated WAT obtained EHD2 del/del vs. EHD2 del/+ mice or in 130 primary adipocyte cell cultures (Fig. S5B-D To characterize the mechanisms of increased lipid accumulation in EHD2 del/del fat cells, lipid 136 metabolism was investigated in cultured adipocytes. Primary pre-adipocytes were isolated from WAT of 137 EHD2 del/+ and EHD2 del/del mice and differentiated into mature adipocytes, followed by BODIPY 138 staining to measure LD sizes. Undifferentiated EHD2 del/del pre-adipocytes showed increased LD size, a 139 difference that was even more pronounced in differentiated EHD2 del/del adipocytes compared to EHD2 140 del/+ ( Fig. 2A-B) . 3D reconstruction of EHD2 del/del differentiated adipocytes illustrates an extensively 141 increased volume of some LDs (Fig. 2C) . 142
We addressed the possibility that increased lipid uptake is a secondary effect of EHD2 deletion 143 mediated via putative organ cross-talk. We therefore repeated the experiments with cultivated 144 adipocytes derived from EHD2 cKO flox/flox mice, in which EHD2 expression was down-regulated by 145 expression of Cre recombinase via viral transfection (AAV8). Again, EHD2 removal led to increased LD 146 growth ( Fig. 2D-E) , indicating a cell-autonomous function of EHD2 in controlling lipid uptake. 147 LD growth is mainly mediated by extracellular fatty acid uptake and conversion into triglycerides, 148 whereas increased glucose uptake and de novo lipogenesis play minor roles in this process (29, 30). Fatty 149 acids and lipids are present at high concentrations in fetal bovine serum (FBS). Addition of delipidated FBS 150 during adipocyte differentiation resulted in complete loss of LD in both genotypes (Fig. S4A) , whereas 151 glucose-depletion led to a general impairment of adipocyte differentiation. Importantly, enlarged LDs 152 were still observed in KO adipocytes even under conditions of glucose depletion (Fig. S4A ). These data led 153 us to hypothesize that the increased LD size in EHD2 del/del adipocytes may be a consequence of 154 increased fatty acid uptake, in line with the suggested function of caveolae in fatty acid uptake (31-33). 155
To test this possibility directly, we monitored the uptake of extracellularly added fatty acids into 156 differentiated adipocytes using BODIPY-labelled dodecanoic acid (FA12) paired with FACS analysis. After 157 5 min, only a minor fraction of EHD2 del/+ adipocytes displayed intense BODIPY staining (R2, for definition 158 see Fig. 2F ). This R2 population increased to more than 30% after 60 min of FA12 treatment. EHD2 del/del 159 adipocytes displayed increased BODIPY staining at both early and late time points ( Fig. 2F-H; Fig. S4B-D) , 160 indicating accelerated lipid uptake. This conclusion was further supported by light microscopy imaging, 161 which revealed more intense BODIPY staining of EHD2 del/del cells compared to EHD2 del/+ adipocytes 162 after 60 min of fatty acid incubation (Fig. 2G) . In contrast, EHD2 del/+ and EHD2 del/del adipocytes did 163 not differ with respect to their ability to take up extracellularly added glucose (Fig. S4E-G) . Previously, an 164 involvement of EHD2 in the autophagic engulfment of LDs (lipophagy) was suggested (34). However, 165
inducing starvation by incubation of differentiated adipocytes with Hank's balanced salt solution (HBSS) 166 revealed no differences in the release of stored lipids in EHD2 del/+ and EHD2 del/del adipocytes, and 167 both genotypes displayed similar reductions in lipid accumulation (Fig. S5A ). These data indicate that loss 168 of EHD2 does not affect the release of fatty acids or lipophagy, but specifically controls LD size by 169 regulating fatty acid uptake. 170
171
Loss of EHD2 results in detachment of caveolae from the plasma membrane in vivo 172
Given the known role of caveolae in the uptake of fatty acids (16), we hypothesized that EHD2 173 may restrict fatty acid uptake by controlling caveolar function and/ or dynamics. To test whether loss of 174 EHD2 affects caveolar morphology, WAT and BAT were analyzed by electron microscopy (EM). Caveolae 175 in EHD2 del/+ BAT were mostly membrane-bound and displayed the characteristic flask-shaped 176 morphology (Fig. 3A , white arrows, ratio detached/membrane bound caveolae = 0.27). Strikingly, an 177 increased number of caveolae appeared detached from the plasma membrane in BAT isolated from EHD2 178 del/del mice compared to EHD2 del/+ controls, as judged from the complete closure of the lipid bilayer in 179 the plasma membrane and the caveolae (Fig. 3A , B, black arrows, ratio detached/membrane bound 180 caveolae = 1.75). The total number of caveolae, as well as the caveolar diameter and size, were unchanged 181 in brown adipocytes lacking EHD2. 182
An increased number of detached caveolae were also observed in EHD2 del/del white adipocytes 183 compared to EHD2 del/+ cells from littermate controls (Fig. 3C , D, black and white arrow heads, ratio 184 detached/membrane bound caveolae (del/del) = 1.2 vs. ratio (del/+) = 0.24). In white adipocytes, the total 185 number of caveolae was reduced, while both caveolar size and diameter were increased in EHD2 del/del 186 compared to EHD2 del/+ animals (Fig. 3D) . Cav1 immunogold labeling confirmed that the round vesicles 187 close the plasma membrane, indeed, were detached caveolae (Fig. 3E ). 3D visualization of EHD2 del/del 188 brown adipocyte by electron tomography (ET) further indicated that the majority of detached caveolae in 189 2D EM images were not connected to the plasma membrane (Fig. 3F , G, Movie S1) but localized 20-30 nm 190 underneath ( Fig. 3G a, b) , although some caveolae close to the plasma membrane showed thin 191 connections ( in EHD2 del/del cells (Fig. 4A, B) . Re-expression of EHD2 in EHD2 del/del MEFs reduced the mobility of 209 caveolae, often leading to their immobilization (Fig. S6, Movie S4) . 210
211
Determinants of EHD2-mediated fatty acid uptake 212
We further characterized the determinants of the observed lipid uptake in MEFs. Similar to EHD2 213 del/del adipocytes, EHD2 del/del MEFs showed increased lipid accumulation and LD size after adipogenic 214 differentiation, as illustrated by Oil red O staining (Fig. S7A ) and BODIPY staining (Fig. S7B, C) . 215
Furthermore, both storage and membrane lipids were increased in MEFs lacking EHD2 (Fig. S7D) . Re-216 expression of an EGFP-tagged EHD2 version in in EHD2 +/+ and del/del MEFs rescued the observed LD 217 phenotype, even reducing the size of LDs compared to EGFP expressing cells (Fig. 5A, B) . These data 218 indicate a general and cell autonomous role of EHD2 in the control of LD growth and size that is not 219 restricted to fat cells. 220
To identify the functional regions within EHD2 that are crucial for regulating lipid uptake, we 221 transfected EHD2 del/del MEFs with various EGFP-tagged EHD2 deletion constructs. EHD2 constructs 222 lacking the N-terminus, the EH-domain or both, rescued EHD2 loss, resulting in smaller LDs (Fig. 5C, S7E) . Our data indicate an EHD2-dependent regulation of lipid uptake in adipose tissue. If this were of 246 physiological relevance, one might expect EHD2 expression to be dysregulated in obese mice and men. 247
We therefore investigated if EHD2 expression is altered in two obesity-related mouse models, ob/ob and 248 NZO (38). Indeed, WAT obtained from ob/ob and NZO mice showed reduced EHD2 expression compared 249 to C57BL6/N mice fed by standard diet (Fig. 6A ). When investigating adipocytes from ob/ob mice, a higher 250 proportion of detached caveolae were found in the obesity mouse model (ratio detached/membrane 251 bound caveolae = 1.4 vs. 0.35 in C57BL6/N mice fed with standard diet, Fig. 6B, C ). In addition, we analyzed 252 EHD2 expression in visceral and subcutaneous WAT from patients ranking in their body mass index (BMI) 253 from normal to morbid obesity (BMI<25 -BMI >40, Fig. 6D , E). In both depots, EHD2 expression was 254 highest in normal weight subjects and was significantly lower in overweight and obese people, whereas 255 EHD2 expression did not differ between different obesity stages. These data imply that EHD2 expression 256 is regulated by lipid uptake and load and suggest that EHD2-mediated caveolar dynamics may be altered 257 in obesity. 258
259
Discussion 260
Here, we identify EHD2 as a negative regulator of caveolae-dependent lipid uptake. Loss of EHD2 261 resulted in increased lipid accumulation, which was observed in adipose tissue of the whole organism as 262 well as in cell culture-based experiments. Loss of EHD2 was associated with the detachment of caveolae 263 from the plasma membrane, higher caveolar mobility and increased lipid uptake. We demonstrate that 264 caveolae, dynamin 2 and the fatty acid translocase CD36 play a role in the EHD2-dependent lipid uptake 265 pathway. In addition, obese mouse models exhibit decreased EHD2 expression in WAT and in addition, 266 also obese patients showed a reduction in EHD2 gene expression. Thus, our study reveals a cell-267 autonomous caveolae dependent lipid uptake route that is controlled by EHD2 and modified by metabolic 268 conditions. 269
For some time, caveolae have been implicated in lipid uptake. Thus, mice lacking caveolae showed 270 reduced fat mass and did not develop any form of obesity. In addition, Pohl et al. (39) observed decreased 271 oleate uptake after expression of a dominant-negative Cav1 mutant. The EHD2 KO mouse model, 272 described here, revealed the opposite phenotype, e.g. a caveolae gain-of-function in vivo model. In EHD2 273 KO mice, caveolae were more often detached from the plasma membrane and showed a higher mobility 274 and faster lipid uptake, resulting in enlarged LDs. Unlike in Cav1 over-expressing mice (19), which also 275 show increased fatty acid uptake, the number of caveolae was not increased in EHD2 KO mice. This 276 supports a model in which not only caveolae number, but also caveolar dynamics play a crucial role in this 277 process (Fig. 6F) The detailed pathway of caveolae-dependent cellular lipid uptake has been intensively studied (4, 283 20, 31, 32, 41), but the exact molecular mechanisms are still unclear. Our observation indicate that fatty 284 acid uptake depends on caveolar dynamics, detachment and most likely caveolae endocytosis and is 285 regulated by EHD2. However, it remains elusive how caveolar shuttling is linked to the growth of lipid 286 droplets. The EHD2 knockout model may be a useful tool to further dissect the molecular lipid uptake 287 mechanism. 288
The loss of EHD2 on the cellular level led to increased fat deposits on the organismic level, which 289 was particularly evident in older animals. The observed phenotype based on the global loss of EHD2 could 290 be influenced by organ-organ interactions (42). However, we did not find any evidence for differences in 291 adipocyte derived secretory factors, such as leptin (Fig. S3) . Furthermore, increased lipid uptake was 292 dependent on caveolae, as shown by Cav1 knockdown experiments, and lipid droplet growth could 293 specifically be induced by viral transfection of Cre recombinase in EHD2 cKO flox/flox, but not in flox/wt 294 adipocytes. Thus, increased lipid uptake is caused by a cell-autonomous, caveolae-dependent mechanism. 295
As the WAT distribution and lipid accumulation is known to differ in male and female mice, further studies 296 are required to analyze potential sex-specific differences in EHD2-dependent lipid uptake. 297
Despite the observed lipid accumulation in mice lacking EHD2, the body weight of EHD2 del/del 298 and EHD2 del/+ mice was unaltered, suggesting metabolic compensation. In line with this idea, EHD2 299 del/del WAT and cultivated EHD2 del/del adipocytes showed a significant reduction in expression levels 300 of genes involved in de novo lipogenesis like SREBP1 or FAS indicating a strong downregulation of glucose-301 dependent fatty acid production in fat cells. Similar compensatory mechanisms were noted in patients 302 suffering from obesity (43-45). Remarkably, the expression levels of EHD2 in WAT from obese patients as 303 well as in WAT of two obese mouse models (ob/ob and NZO mice) and of EHD2 del/+ mice treated with a 304 long-term high fat diet were significantly reduced. Thus, expression of EHD2 appears to negatively 305 correlate with adipocyte size, therefore reflecting the situation in the EHD2 KO mouse (see also (46)). We 306 speculate that an imbalance in number, life-time and mobility of caveolae may accompany and possibly 307 actively contribute to the development and progression of obesity. Accordingly, pharmacological 308 approaches to enhance EHD2 expression or its stabilization at the plasma membrane could reduce lipid 309 uptake and consequently help to treat obesity in patients. 310
In conclusion, our study reveals that EHD2 controls a caveolae-dependent cellular lipid uptake 311 pathway. 312 313
Methods 314
Please see SI for detailed description of all methods and material. 315 EHD2 delta E3 mouse strain generation. The EHD2 targeting construct was generated by insertion of two 316 lox P sequences flanking exon 3 of EHD2 genomic DNA by homologous recombination in E.coli as 317 previously described (47) including a pGK Neomycin and a diphtheria toxin A (DTA) cassette. 318
Electroporation of the linearized targeting vector in R1 ES cells was performed. Mice carrying a loxP-319 flanked Exon 3 of EHD2 gene were mated to Cre deleter mice to generate EHD2 mutant (del/del) mice. 320
After backcrossing the EHD2 del/del mice with C57BL6/N (Charles River, between 20-30 weeks, male) for 321 6 generations only male EHD2 del/del or EHD2 del/+ (as control) mice were used and littermates were 322 randomly assigned to experimental groups. All animals were handled accordingly to governmental animal 323 welfare guidelines and were housed under standard conditions. 324 Fatty acid uptake assay. EHD2 del/+ and EHD2 del/del pre-adipocytes were seeded in 6-well plates 354 (100.000 cells/well) and differentiated in mature adipocytes as described above. The fatty acid uptake 355 assay was performed as described elsewhere (51). Briefly, differentiated adipocytes were starved for 1 h 356 with serum-free DMEM. Next, 2 µM dodecanoic acid (FA12) labelled with BODIPY (Molecular probes 357 #D3822) diluted in serum-free DMEM + 10 µg/ml insulin was added to the adipocytes and incubated for 
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The authors declare no competing interests. 383 and afterwards treated for 6 h with oleic acid and Nile Red staining was performed to determine LDs 564 (pEGFP: n(+/+) = 309/3, n(del/del) = 310/3; pEHD2-EGFP: n(+/+) = 218/4, n(del/del) = 184/4). 565 C EHD2 constructs were transfected in EHD2 del/del MEFs and after 48h treated with oleic acid and Nile 566
Red staining was performed to determine LDs (n(pEGFP) = 275/3; n(pEHD2-deltaN-EGFP) = 193/3; 567 n(pEHD2-deltaEH-EGFP) = 197/3; n(pEHD2-deltaN-EH-EGFP) = 196/3; n(pEHD2-F322A-EGFP) = 204/3; 568 n(pEHD2-F122A-EGFP) = 212/3). 569
D-E EHD2 del/del MEFs were treated with Cav1 siRNA and lipid droplets were stained with BODIPY 570 (negative control: n(+/+) = 504/3, n(del/del) = 530/3; Cav1 siRNA: n(+/+) = 521/3, n(del/del) = 558/3); Clth 571 HC -clathrin heavy chain. 572 F-G EHD2 +/+ and del/del MEFs were transfected with either pGFP-Dyn2-K44A, incubated for 18 h and 573 afterwards treated for 6 h with oleic acid and Nile Red staining was performed to determine LDs (pEGFP: 574 n(+/+) = 309/3, n(del/del) = 233/4; pGFP-Dyn2-K44A: n(+/+) = 136/3, n(del/del) = 237/4). 575 H-I LD size after CD36 siRNA knockdown in EHD2 +/+ and del/del MEFs (D, negative control: n(+/+) = 584/6, 576 n(del/del) = 475/6; CD36 siRNA#1: n(+/+) = 341/3, n(del/del) = 249/3; CD36 siRNA#2: n(+/+) = 412/3, 577 n(del/del) = 468/3; CD36 siRNA#3: n(+/+) = 251/3, n(del/del) = 368/3; graph illustrates each replicate with 578 mean +/-SE, 2-way ANOVA test were used to calculate significance between siRNA negative CTRL and 579 siRNA, t-test was used between +/+ and del/del data). 580
Box plots indicate mean +/-SE and single replicates of 5% of maximal and minimum values are illustrated, 581 t-test or Mann Withney U test were used to calculate significance, *** P<0.0001. See also Fig. S7 . D-E EHD2 expression in visceral (E) or subcutaneous WAT (F) in obese patients (n(normal) = 31; 591 n(overweight) = 23; n(obesity grade 1) = 7; n(obesity grade 2) = 17; n(obesity grade 3) = 202). 592 F The model illustrates how fatty acid uptake is affected by caveolae function. In the absence of caveolae, 593 lipid uptake is reduced resulting in smaller lipid droplets compared to normal conditions. In the absence 594 of EHD2, lipid uptake is increased, suggesting a regulatory function of EHD2 in caveolae-dependent lipid 595 uptake. FFA -Free fatty acid, LD -lipid droplet. 596
Box plots indicate median with whiskers from maximal to minimum value, or each replicate with mean 597 +/-SE is represented, normal distributed groups were analyzed by t-test, not normal distributed values 598
with Mann Withney U test, * P<0.05, *** P<0.0001. 599 600
Supporting Information 601
Extended Material and Methods 602
Mouse embryonic fibroblast isolation and immortalization. All animals were handled accordingly to 603 governmental animal welfare guidelines. MEFs were obtained from E14.5 EHD2 +/+ or del/del embryos. 604
Therefore female, pregnant EHD2 del/+ were sacrificed by cervical dislocation, the embryos were 605 dissected and removed from the yolk sac in sterile, cold PBS. For genotyping, a small piece of each mouse 606 embryo tail was harvested followed by complete dissection of the whole embryo. Afterwards, the embryo 607 pieces were treated with 0.25% trypsin/EDTA (Sigma) over night at 4 °C. After aspiration of the trypsin 608 solution, 10 ml culture medium (DMEM/10%FBS/5% penicillin/streptomycin) was added and tissue pieces 609 were break up by pipetting. The cell suspension was transferred in 75 cm 2 culture flask for cultivation at 610 37 °C and 5% CO 2 . Immortalization of isolated primary MEFs was assured by frequently splitting. with culture medium (DMEM/10%FBS/5% penicillin/streptomycin), SVF was obtained after 5 min 620 centrifugation at 1,000 rpm. After complete tissue break up the adipocyte cell suspension was passed 621 through a 270 µm cell strainer and the cells were plated in 75 cm 2 culture flask at 37 °C and 5% CO 2 622 whereby pre-adipocytes adhere to the flask and mature adipocytes float in the medium. SVF suspension 623 was cleaned by passing through 70 µm cell strainer. The following day the culture medium was exchanged 624 to remove dead or non-adherent cells. After 5 days, both pre-adipocytes and SVF were split by 0.25% 625 trypsin/EDTA solution and merged for further cultivation. Differentiation to mature adipocytes was 626 induced by 10 µg/ml insulin, 2.5 mM dexamethasone, 50 mM IBMX and 25 mM rosiglitazone diluted in 627 culture medium. If not otherwise mentioned the primary pre-adipocytes were incubated for 5 days with 628 differentiation medium and medium was changed after 2 days. Delipidation of FBS was carried out as 629 described by (1). EHD2 cKO adipocytes were transfected with Cre recombinase-EGFP by using adeno-630
Transfection and siRNA knockdown. Cultivated MEFs were transfected with the following plasmids 663 pEHD2-EGFP, pEHD2-deltaN-EGFP, pEHD2-deltaEH-EGFP, pEHD2-deltaN-EH-EGFP, pEHD2-F322A-EGFP, 664 pEHD2-F122A-EGFP, pCav1-EGFP (provided from R.L.), pGFP-Dyn2-K44A (provided from M.L., addgene 665 #22301) or pEGFP by lipofectamine 3000 (Invitrogen) accordingly to the manufacture's protocol. 666
Transfected cells were incubated for 48 h and afterwards the treated cells were analyzed by confocal 667 microscopy or TIRF. siRNA knockdown of CD36 or Cav1 was performed in freshly split MEFs by 668 electroporation with the GenePulser XCell (Biorad). Briefly, MEFs were split as described before and the 669 obtained cell pellet was resuspended in OptiMEM (Gibco). After cell counting, the MEF cell suspension 670 was diluted to 1.5x10 6 cells/ml and 300 µl were transferred into electroporation cuvettes (2 mm, Biorad). 671 
